Release of matrix metalloproteinases-1 and-2, but not-9, from activated platelets measured by enzyme-linked immunosorbent assay

Platelets

Volumn 22, Issue 8, 2011, Pages 572-578

  Klvegren, Hanna ^a,b   Jönsson, Simon ^b   Jonasson, Lena ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

Author keywords

Matrix metalloproteinase, platelets

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; THROMBIN; TOLL LIKE RECEPTOR AGONIST;

ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PLATELET ACTIVATION; THROMBIN;

EID: 80455168376     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.583300     Document Type: Article

References (23)

1. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573. (Pubitemid 43139720)
2. Lehrke M, Greif M, Broedl UC, Lebherz C, Laubender RP, Becker A, Von Ziegler F, Tittus J, Reiser M, Becker C, et al. MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovasc Diabetol 2009;8:50.
3. Tayebjee MH, Lip GY, Tan KT, Patel JV, Hughes EA, MacFadyen RJ. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 2005;96:339-345. (Pubitemid 41058855)
4. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004;110:1747-1753. (Pubitemid 39299216)
5. Szymanowski A, Nijm J, Kristenson M, Jonasson L. Elevated levels of circulating matrix metalloproteinase-9 are associated with a dysregulated cortisol rhythm-A case-control study of coronary artery disease. Psychoneuroendocrinology 2011; 36:139-143.
6. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003;107:1579-1585. (Pubitemid 36397324)
7. Fernandez-Patron C, Martinez-Cuesta MA, Salas E, Sawicki G, Wozniak M, Radomski MW, Davidge ST. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and-2. Thromb Haemost 1999; 82:1730-1735.
8. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res 2008;121:535-542. (Pubitemid 351174273)
9. Galt SW, Lindemann S, Allen L, Medd DJ, Falk JM, McIntyre TM, Prescott SM, Kraiss LW, Zimmerman GA, Weyrich AS. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002; 90:1093-1099. (Pubitemid 34627908)
10. Jung K, Mannello F, Lein M. Translating molecular medicine into clinical tools: Doomed to fail by neglecting basic preanalytical principles. J Transl Med 2009;7:87.
11. Mannello F. Serum or plasma samples? The "Cinderella" role of blood collection procedures: Preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. Arterioscler Thromb Vasc Biol 2008;28:611-614. (Pubitemid 351651318)
12. Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clin Biochem 2007;40:119-123. (Pubitemid 46014168)
13. Sheu JR, Fong TH, Liu CM, Shen MY, Chen TL, Chang Y, Lu MS, Hsiao G. Expression of matrix metalloproteinase-9 in human platelets: Regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol 2004;143:193-201. (Pubitemid 39280039)
14. Falcinelli E, Giannini S, Boschetti E, Gresele P. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: Lack of inhibition by aspirin. Br J Haematol 2007;138:221-230. (Pubitemid 46976318)
15. Trivedi V, Boire A, Tchernychev B, Kaneider NC, Leger AJ, O'Callaghan K, Covic L, Kuliopulos A. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 2009;137:332-343.
16. Kalvegren H, Majeed M, Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: A causal role in cardiovascular disease? Arterioscler Thromb Vasc Biol 2003;23:1677-1683. (Pubitemid 37108216)
17. Jennings LK. Role of platelets in atherothrombosis. Am J Cardiol 2009;103:4A-10A.
18. Kalvegren H, Skoglund C, Helldahl C, Lerm M, Grenegard M, Bengtsson T. Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2\2 mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation. Thromb Haemost 2009;103:398-407.
19. Monaco C, Gregan SM, Navin TJ, Foxwell BM, Davies AH, Feldmann M. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 2009;120:2462-2469.
20. Falcinelli E, Guglielmini G, Torti M, Gresele P. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost 2005;3:2526-2535. (Pubitemid 41727170)
21. Momi S, Falcinelli E, Giannini S, Ruggeri L, Cecchetti L, Corazzi T, Libert C, Gresele P. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med 2009;206:2365-2379.
22. Tayebjee MH, Lip GY, Tan KT, MacFadyen RJ. Abnormal circulating neutrophil linked matrix metalloproteinase-9 in stable coronary artery disease. Thromb Haemost 2006; 95:202-204.
23. Cataldo D, Munaut C, Noel A, Frankenne F, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy 2001;56:145-151. (Pubitemid 32115765)